Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Therapeutics (MT) and Population Studies Research Program (PS Research Program).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

Other Karmanos Programs

The Latest From Karmanos Cancer Institute

News

Catching Lung Cancer Early Could Save Your Life

Lung cancer is the leading cause of cancer-related deaths in the U.S. and the second most common cancer for both men and women, according to the A...

Read More

Karmanos Cancer Institute Reveals New Brand Campaign, Showcasing Cancer Survivors and Local Community Businesses

From the patients served by the Barbara Ann Karmanos Institute to the businesses and organizations that Karmanos patients support, Karmanos has la...

Read More

Have 10 Minutes? Here’s What You Need to Know About Cancer Clinical Trials

Did you know that a cancer clinical trial is a research study that examines new cancer-fighting drugs, surgical methods, diagnostic tests, or meth...

Read More
News

WWJ | ‘Houses with Roofs Caved In’: Karmanos Surgeon Explains Stage 0 Breast Cancer (DCIS)

Listen Now

WWJ | Treatment Plans, Clinical Trials and Second Opinions: Navigating a Breast Cancer Diagnosis

Listen Now

Sunday Edition | Second Opinions, Clinical Trials and Second Opinions in Breast Cancer

Listen Now